Filtered By:
Education: Study
Nutrition: Sodium
This page shows you your search results in order of relevance. This is page number 7.
Order by Relevance | Date
Total 641 results found since Jan 2013.
Association between Plasma Osmolality and Case Fatality within 1 Year after Severe Acute Ischemic Stroke
CONCLUSION: Elevated plasma osmolality was independently associated with 3-month case fatality, but not 1-year case fatality, for severe acute ischemic stroke.PMID:34164957 | DOI:10.3349/ymj.2021.62.7.600
Source: Yonsei Medical Journal - June 24, 2021 Category: Universities & Medical Training Authors: Meng Liu Yilun Deng Yajun Cheng Zilong Hao Simiao Wu Ming Liu Source Type: research
Post-stroke seizures: risk factors and management after ischemic stroke
AbstractStroke is the leading cause of epilepsy in the elderly, ahead of degenerative diseases, tumors and head injuries. It constitutes a significant complication and a considerable comorbidity. The aim of our study was to describe the main factors implicated in the occurrence of post-stroke seizures and to identify the predictors of seizure recurrence. We conducted a descriptive, retrospective, monocentric study from January 2010 to December 2019, including patients who presented seizures following an ischemic stroke. We classified these seizures according to the International League Against Epilepsy (ILAE) into acute sy...
Source: Acta Neurologica Belgica - July 12, 2021 Category: Neurology Source Type: research
Association between Plasma Osmolality and Case Fatality within 1 Year after Severe Acute Ischemic Stroke
CONCLUSION: Elevated plasma osmolality was independently associated with 3-month case fatality, but not 1-year case fatality, for severe acute ischemic stroke.PMID:34164957 | PMC:PMC8236343 | DOI:10.3349/ymj.2021.62.7.600
Source: Yonsei Medical Journal - June 24, 2021 Category: Universities & Medical Training Authors: Meng Liu Yilun Deng Yajun Cheng Zilong Hao Simiao Wu Ming Liu Source Type: research
The Role of Combined SGLT1/SGLT2 Inhibition in Reducing the Incidence of Stroke and Myocardial Infarction in Patients with Type 2 Diabetes Mellitus
ConclusionsThe role of SGLT1/2 inhibition as an addition to GLP-1 RAs in patients with and without T2DM at increased risk for MI and stroke requires further study. Regardless, the finding that a relative increase in SGLT1/2 inhibition reduces the risk of MI and stroke as well as hospitalizations and urgent visits for heart failure could improve quality of life and reduce the healthcare burden associated with T2DM.
Source: Cardiovascular Drugs and Therapy - November 9, 2021 Category: Cardiology Source Type: research
